Capstone Investment Advisors
BNGO icon

Capstone Investment Advisors’s Bionano Genomics BNGO Stock Holding History

Capstone Investment Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24
Closed -$118K – 1721
2021
Q1 		$118K Buy
+24
New +$135K ﹤0.01% 1501

Other funds holding BNGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Capstone Investment Advisors's BNGO Position: Q2 2021 in Review

Capstone Investment Advisors sold out of Bionano Genomics (BNGO) in Q2 2021, closing a stake of 24 shares — an estimated $118K sold.

Capstone Investment Advisors first reported a position in BNGO in Q1 2021 and held it in 1 quarter. The position peaked at $118K in Q1 2021. 152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

  • Capstone Investment Advisors reported no remaining Bionano Genomics position as of Q2 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 24 Bionano Genomics shares in Q2 2021, an estimated $118K.
  • Capstone Investment Advisors first reported a position in Bionano Genomics in Q1 2021 and held it in 1 quarter.
  • Capstone Investment Advisors's Bionano Genomics position peaked at $118K in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on Capstone Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.